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Current ACCP guidelines miss a substantial proportion of
LEDVTs in critically ill trauma patients, especially when
CVDVTs are included in the investigation. Routine DUS of
all critically ill trauma patients will detect a high number of
asymptomatic LEDVTs, 15.2% in our study. Diagnosis
of these otherwise undetected DVTs can lead to thera-
peutic anticoagulation, IVC filter placement, or contin-
ued surveillance depending on institutional practices.
DUS screening appears to be a useful adjunct to current
protocols of DVT prevention, detection, and treatment
in trauma ICUs. We recommend early and ongoing
surveillance of all critically ill trauma patients for all lower
extremity DVTs regardless of injury patterns, DVT risk
factors, or the presence of pharmacologic prophylaxis.
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Dr James Watson (Seattle, Wash). Dr Azarbal and his col-
leagues have reminded us that severely injured trauma patients arer symptoms concerning DVT with duplex ultrasound studies.
f those 264 asymptomatic patients, 40 (15%) had evidence of
VT and 25 (63%) of those were calf DVTs. This frequency of
VT is higher than that found by others1 and is similar to the
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September 2011748 Azarbal et al16.9% rate found in a systematic review of asymptomatic spinal
cord injury patients,2 a group at higher risk for DVT than
trauma patients.
It is not surprising that they found older patients and those
with a lower admission Glasgow Coma Score were more likely to
suffer a DVT and subsequently spend more time in the ICU than
those who did not develop a DVT. It is surprising that high-risk
injuries and higher injury severity scores did not correlate with a
higher risk of developing DVT.
Another unexpected finding was that the prophylactic admin-
istration of low molecular weight heparin did not provide any
protection against the development of DVT. We are not provided
any data about the timing of prophylaxis initiation or how fre-
quently anticoagulation was interrupted, either of which may
interfere with the efficacy of prophylaxis. It has been shown that
prophylaxis can safely be started within 36 hours of injury and need
not be interrupted for most surgical procedures due to concern
over excess bleeding.3
Cost data is of paramount importance in this economic cli-
mate. The authors appropriately point out that Meythaler showed
the cost per year of life saved for duplex scanning of brain injured
patients was only $2977,4 which is less than the cost of mammog-
raphy or fecal occult blood testing. The cost of “screening” for
asymptomatic patients is significant. I suspect we will, and should,
see a lot more specific economic data such as the “incremental cost
effectiveness ratio” of duplex scanning for various clinical situa-
tions in the near future. Providing good patient care is not enough
anymore. We need to ensure that what we do is not only medically
necessary but also that it makes economic sense for society.
I have several questions for the authors:
What is your current protocol for DVT prophylaxis in trauma
patients? Have you changed your recommendations in favor of
more aggressive prophylaxis? Do you think chemical prophylaxis
should be altered for operative procedures?
Dr Amir Azarbal. Thank you for your comments, Dr Wat-
son. Our current protocol is to start prophylactic dose LMWH at
30 mg SC bid as upon admission to the trauma ICU, unless there
is a contraindication. The decision to interrupt LMWH prophy-
laxis for procedures is left to the discretion of the surgeon perform-
ing the procedure. Most general surgical procedures are done
without interruption of the prophylaxis, while orthopedic and
neurosurgical procedures are more likely to result in a halting of
prophylaxis.
As for recommendations for more aggressive prophylaxis, we
have an ongoing study evaluating factor Xa levels and other objec-
tive measures of anticoagulation to help determine optimal levels
of LMWH prophylaxis in trauma patients. However this study is
still in its preliminary stages.DrWatson.How do you decide which asymptomatic patients
eed weekly scans? Do you only scan patients in the ICU or do you
lso include other high-risk patients with limited mobility who may
e in intermediate-care units or even on the regular ward?
Dr Azarbal.Currently, we scan all patients in the trauma ICU
eekly. Duplex ultrasound screening of ward patients considered
o be at high risk for developing DVTs is performed at the
iscretion of the trauma service attending and not done based on
rotocol.
Dr Watson. Does your lab get paid for screening venous
uplex examinations in asymptomatic patients?
DrAzarbal.No, screening studies are not currently reimburs-
ble and are done as part of a study protocol. Hopefully, with
ost-effectiveness data, such as the study by Meytheler et al4
creening studies will become reimbursable in the future.
Dr Watson. Are there any other tests you find useful in
etecting DVT? Specifically, would a positive or negative D-dimer
ssay have any effect on your decision to obtain, or not obtain a
uplex examination in an asymptomatic patient?
Dr Azarbal. D-dimer assays have been helpful due to their
igh negative predictive value in medical patients. However, in the
cute trauma setting the D-dimer assay can have a high false
egative rate.5 Therefore, given the high DVT rate of the trauma
CU population, I do not believe a normal D-dimer assay would be
ssuring enough to preclude duplex ultrasound screening. D-
imer assays may have more of a role in continued surveillance of
rauma patients as the time from injury increases.5 Conversely,
-dimer assays are often elevated in trauma patients; and therefore,
do not believe a positive D-dimer assay using current accepted
alues would be helpful.
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